Our site may be slower due to heavy traffic from automated "bots" and AI crawlers. We're working to fix this.

Kincheon Li

Photo of Kincheon Li
Title(s)Assistant Adjunct Professor, Pediatrics
SchoolVc-health Sciences-schools
ORCID ORCID Icon0000-0001-6640-2625 Additional info
vCardDownload vCard

    Collapse Biography 
    Collapse education and training
    University of Toronto, TorontoMD06/2012Medicine
    University of Toronto, TorontoResidency06/2016Pediatrics
    University of Toronto, TorontoFellowship06/2018Pediatric Hematology/Oncology
    Memorial Sloan Kettering Cancer Center, New YorkFellowship07/2022Pediatric Neuro-Oncology
    University of Toronto, TorontoPhD08/2025Cancer Pathobiology
    Collapse awards and honors
    Hold’em for Life Charity2020  - 2021Hold’em for Life Charity Oncology Fellowship
    Society for Neuro-Oncology2019Pediatric Basic Science Award (top abstract, SNO Annual Meeting)
    Hospital for Sick Children, University of Toronto2019  - 2021Clinician-Scientist Training Program
    Garron Family Cancer Centre2018  - 2021GFCC Research Fellowship
    Conquer Cancer Foundation of American Society of Clinical Oncology2018Merit Award (top abstract, ASCO Annual Meeting)

    Collapse Overview 
    Collapse overview
    Dr. Li is a pediatric hematologist/oncologist and physician-scientist focusing on aggressive childhood brain tumors at Rady Children’s Hospital and UC San Diego.

    He completed most of his medical and research training at the University of Toronto and the Hospital for Sick Children, including medical school, pediatrics residency, pediatric hematology/oncology fellowship, and a PhD under advisor Dr. Annie Huang. He was among the first scientists to define the now World Health Organization-recognized molecular subgroups of pineoblastoma, a rare but highly lethal brain tumor arising in young children. He later completed a pediatric neuro-oncology fellowship at Memorial Sloan Kettering Cancer Center in New York, before joining the Icahn School of Medicine at Mount Sinai as an Assistant Professor of Pediatrics.

    Under the mentorship of Dr. Praveen Raju beginning at Mount Sinai, and continuing at Rady’s and UCSD, he has been studying how to circumvent the blood-brain barrier to improve therapies for highly aggressive childhood brain tumors like diffuse intrinsic pontine glioma (DIPG)/diffuse midline glioma (DMG). Specifically, he has been developing novel P-selectin targeting nanomedicines to package anti-cancer therapeutics, enhancing their delivery into the tumor space while sparing normal brain tissue to reduce side-effects.

    Clinically, he primarily works with the Neuro-Oncology and Solid Tumor programs in the outpatient clinic and inpatient unit.

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Phase 3 randomized trial of high-dose methotrexate for young children with high-risk embryonal brain tumors: A report from the Children's Oncology Group. Neuro Oncol. 2025 Oct 01; 27(10):2726-2737. Mazewski C, Leary SES, Kang G, Li BK, Kellie S, Hayes L, Shaw D, Ho B, Reddy A, Gossett J, Burger PC, Judkins AR, Aridgides P, Geyer JR, Gajjar A, Pollack IF, Fouladi M, Huang A. PMID: 40485042; PMCID: PMC12833527.
      View in: PubMed   Mentions: 1     Fields:    
    2. A population-based analysis of the molecular landscape of glioma in adolescents and young adults reveals insights into gliomagenesis. Nat Cancer. 2025 Jun; 6(6):1102-1119. Bennett J, Levine AB, Nobre L, Negm L, Chung J, Fang K, Johnson M, Komosa M, Krumholtz S, Nunes NM, Rana M, Ryall S, Sheth J, Siddaway R, Bale TA, Bouffet E, Cusimano MD, Das S, Detsky J, Dirks P, Karajannis MA, Kongkham P, Giantini-Larsen A, Li BK, Lim-Fat MJ, Lin AL, Mason WP, Miller A, Perry JR, Sahgal A, Sait SF, Tsang DS, Zadeh G, Laperriere N, Nguyen L, Gao A, Keith J, Munoz DG, Tabori U, Hawkins C. PMID: 40335748.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    3. SNO-EANO-EURACAN consensus on management of pineal parenchymal tumors. Neuro Oncol. 2024 Dec 05; 26(12):2159-2173. Liu APY, Li BK, Vasiljevic A, Dewan MC, Tamrazi B, Ertl-Wagner B, Hansford JR, Pfaff E, Mynarek M, Ng HK, Tsang DS, Gottardo NG, Gajjar A, Bouffet E, Dufour C, Pizer B, Schiff D, Jenkinson MD, Lombardi G, Wen PY, van den Bent MJ, Huang A. PMID: 39073785; PMCID: PMC11630543.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    4. Clinical outcome of pediatric medulloblastoma patients with Li-Fraumeni syndrome. Neuro Oncol. 2023 12 08; 25(12):2273-2286. Kolodziejczak AS, Guerrini-Rousseau L, Planchon JM, Ecker J, Selt F, Mynarek M, Obrecht D, Sill M, Autry RJ, Stutheit-Zhao E, Hirsch S, Amouyal E, Dufour C, Ayrault O, Torrejon J, Waszak SM, Ramaswamy V, Pentikainen V, Demir HA, Clifford SC, Schwalbe EC, Massimi L, Snuderl M, Galbraith K, Karajannis MA, Hill K, Li BK, Walsh M, White CL, Redmond S, Loizos L, Jakob M, Kordes UR, Schmid I, Hauer J, Blattmann C, Filippidou M, Piccolo G, Scheurlen W, Farrag A, Grund K, Sutter C, Pietsch T, Frank S, Schewe DM, Malkin D, Ben-Arush M, Sehested A, Wong TT, Wu KS, Liu YL, Carceller F, Mueller S, Stoller S, Taylor MD, Tabori U, Bouffet E, Kool M, Sahm F, von Deimling A, Korshunov A, von Hoff K, Kratz CP, Sturm D, Jones DTW, Rutkowski S, van Tilburg CM, Witt O, Bougeard G, Pajtler KW, Pfister SM, Bourdeaut F, Milde T. PMID: 37379234; PMCID: PMC10708940.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    5. Recurrent TRAK1::RAF1 Fusions in pediatric low-grade gliomas. Brain Pathol. 2023 09; 33(5):e13185. Benhamida JK, Harmsen HJ, Ma D, William CM, Li BK, Villafania L, Sukhadia P, Mullaney KA, Dewan MC, Vakiani E, Karajannis MA, Snuderl M, Zagzag D, Ladanyi M, Rosenblum MK, Bale TA. PMID: 37399073; PMCID: PMC10467040.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    6. YAP1-MAML2 fusion in a pediatric NF2-wildtype intraparenchymal brainstem schwannoma. Acta Neuropathol Commun. 2022 08 19; 10(1):117. Karajannis MA, Li BK, Souweidane MM, Liechty B, Yao J, Benhamida JK, Bale TA, Rosenblum MK. PMID: 35986430; PMCID: PMC9392329.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    7. Infantile suprasellar tumor diagnosed as a pineoblastoma RB1 subgroup and treatment challenges: A pediatric SNO Molecular Tumor Board. Neurooncol Adv. 2022 Jan-Dec; 4(1):vdac092. Rubens JA, Erker C, Lindsay H, Ho B, Li B, Bouffet E, Cohen A, Eberhart C, Ertl-Wagner B, Mahajan A, Zacharoulis S, Huang A, Packer R. PMID: 35821675; PMCID: PMC9268732.
      View in: PubMed   Mentions: 1  
    8. Pediatric pineoblastoma: A pooled outcome study of North American and Australian therapeutic data. Neurooncol Adv. 2022 Jan-Dec; 4(1):vdac056. Hansford JR, Huang J, Endersby R, Dodgshun AJ, Li BK, Hwang E, Leary S, Gajjar A, Von Hoff K, Wells O, Wray A, Kotecha RS, Raleigh DR, Stoller S, Mueller S, Schild SE, Bandopadhayay P, Fouladi M, Bouffet E, Huang A, Onar-Thomas A, Gottardo NG. PMID: 35664557; PMCID: PMC9154333.
      View in: PubMed   Mentions: 8  
    9. Clinical and molecular heterogeneity of pineal parenchymal tumors: a consensus study. Acta Neuropathol. 2021 05; 141(5):771-785. Liu APY, Li BK, Pfaff E, Gudenas B, Vasiljevic A, Orr BA, Dufour C, Snuderl M, Karajannis MA, Rosenblum MK, Hwang EI, Ng HK, Hansford JR, Szathmari A, Faure-Conter C, Merchant TE, Levine M, Bouvier N, von Hoff K, Mynarek M, Rutkowski S, Sahm F, Kool M, Hawkins C, Onar-Thomas A, Robinson GW, Gajjar A, Pfister SM, Bouffet E, Northcott PA, Jones DTW, Huang A. PMID: 33619588; PMCID: PMC9302019.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansCells
    10. WNT-activated embryonal tumors of the pineal region: ectopic medulloblastomas or a novel pineoblastoma subgroup? Acta Neuropathol. 2020 10; 140(4):595-597. Liu APY, Priesterbach-Ackley LP, Orr BA, Li BK, Gudenas B, Reddingius RE, Suñol M, Lavarino CE, Olaciregui NG, Santa-María López V, Fisher MJ, Hazrati LN, Bouffet E, Huang A, Robinson GW, Wesseling P, Northcott PA, Gajjar A. PMID: 32772175; PMCID: PMC7501206.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    11. Modeling germline mutations in pineoblastoma uncovers lysosome disruption-based therapy. Nat Commun. 2020 04 14; 11(1):1825. Chung PED, Gendoo DMA, Ghanbari-Azarnier R, Liu JC, Jiang Z, Tsui J, Wang DY, Xiao X, Li B, Dubuc A, Shih D, Remke M, Ho B, Garzia L, Ben-David Y, Kang SG, Croul S, Haibe-Kains B, Huang A, Taylor MD, Zacksenhaus E. PMID: 32286280; PMCID: PMC7156401.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansAnimalsCells
    12. Pediatric embryonal brain tumors in the molecular era. Expert Rev Mol Diagn. 2020 03; 20(3):293-303. Li BK, Al-Karmi S, Huang A, Bouffet E. PMID: 31917601.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    13. Pineoblastoma segregates into molecular sub-groups with distinct clinico-pathologic features: a Rare Brain Tumor Consortium registry study. Acta Neuropathol. 2020 02; 139(2):223-241. Li BK, Vasiljevic A, Dufour C, Yao F, Ho BLB, Lu M, Hwang EI, Gururangan S, Hansford JR, Fouladi M, Nobusawa S, Laquerriere A, Delisle MB, Fangusaro J, Forest F, Toledano H, Solano-Paez P, Leary S, Birks D, Hoffman LM, Szathmari A, Faure-Conter C, Fan X, Catchpoole D, Zhou L, Schultz KAP, Ichimura K, Gauchotte G, Jabado N, Jones C, Loussouarn D, Mokhtari K, Rousseau A, Ziegler DS, Tanaka S, Pomeroy SL, Gajjar A, Ramaswamy V, Hawkins C, Grundy RG, Hill DA, Bouffet E, Huang A, Jouvet A. PMID: 31820118; PMCID: PMC7673644.
      View in: PubMed   Mentions: 53     Fields:    Translation:Humans
    14. Molecular Classification and Management of Rare Pediatric Embryonal Brain Tumors. Curr Oncol Rep. 2018 07 11; 20(9):69. Sin-Chan P, Li BK, Ho B, Fonseca A, Huang A. PMID: 29995179.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    15. Surveillance imaging and radiation exposure in the detection of relapsed neuroblastoma. Pediatr Blood Cancer. 2016 10; 63(10):1786-93. Owens C, Li BK, Thomas KE, Irwin MS. PMID: 27304424.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansPHPublic Health
    16. Chemotherapy induces NEDP1-mediated destabilization of MDM2. Oncogene. 2010 Jan 14; 29(2):297-304. Watson IR, Li BK, Roche O, Blanch A, Ohh M, Irwin MS. PMID: 19784069.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansCells
    Kincheon's Networks
    Concepts (94)
    Derived automatically from this person's publications.
    _
    Co-Authors (5)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _